glp-1 antagonist and Anesthesia: Considerations and Cautions for CRNAs Evolution of GLP‐1 Receptor Agonists

Zepbound may be better suited for some individuals, while Wegovy, an FDA-approved GLP-1 medication, has shown strong results for many

Patients with certain genetic variants may experience stronger appetite suppression and correspondingly greater reductions in natural thirst perception, requiring more deliberate hydration protocols

Figure 1 The safety profile of GLP-1 receptor agonists has been evaluated in several meta-analyses

The FDA has warned patients of serious and potentially life-threatening risks posed by compounders that use non-sterile ingredients to make knockoff weight loss injectables

There is limited data on their safety during breastfeeding